What was the rationale and design framework for LEADER? What were the inclusionary and exclusionary criteria and what was the objective as it relates to the GLP-1 RA liraglutide?

What was the rationale and design framework for LEADER? What were the inclusionary and exclusionary criteria and what was the objective as it relates to the GLP-1 RA liraglutide?

What was the rationale and clinical design framework for the LEADER trial? What were the inclusionary and exclusionary criteria and what was the objective of the trial as it relates to the GLP-1 RA liraglutide?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Josep Vidal, MD, PhD

Josep Vidal, MD, PhD

Obesity Unit, Endocrinology and Diabetes Unit
University Hospital Clinic
Barcelona, Spain